Citius Pharmaceuticals, Inc. – Trademark Portfolio

Entity Type: 03

Citius Pharmaceuticals, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LYMPHIR and MINO-LOK. The owner is based in Cranford, NJ.

11 Commerce Drive, First Floor

Cranford, NJ 07016

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LYMPHIR
LYMPHIR
Registered 2023
DEFYNTAK
DEFYNTAK
Abandoned 2022
TAKCIUS
TAKCIUS
Abandoned 2022
IMSC
IMSC
Abandoned 2020
MINO-LOK
MINO-LOK
Registered 2017

Trademark Classifications

Citius Pharmaceuticals, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Citius Pharmaceuticals, Inc. have?

Citius Pharmaceuticals, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.

What trademark classes does Citius Pharmaceuticals, Inc. file in?

Citius Pharmaceuticals, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Citius Pharmaceuticals, Inc.'s most well-known trademarks?

Citius Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as LYMPHIR and MINO-LOK. These are among 2 currently registered trademarks in the portfolio.

What is Citius Pharmaceuticals, Inc.'s trademark registration success rate?

Citius Pharmaceuticals, Inc. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.